Back to Search
Start Over
Corrigendum to "Long-term efficacy and safety of once-monthly Risperidone ISM® in the treatment of schizophrenia: Results from a 12-month open-label extension study" [Schizophr. Res. 239 (2022) 83-91].
- Source :
-
Schizophrenia research [Schizophr Res] 2022 Aug; Vol. 246, pp. 258-259. Date of Electronic Publication: 2022 Jul 16. - Publication Year :
- 2022
Details
- Language :
- English
- ISSN :
- 1573-2509
- Volume :
- 246
- Database :
- MEDLINE
- Journal :
- Schizophrenia research
- Accession number :
- 35853294
- Full Text :
- https://doi.org/10.1016/j.schres.2022.06.037